Ep. 115 - Initiate's Owens on what it takes to be AI-native

As AI becomes increasingly commoditized, Initiate Ventures' Jessica Owens argues healthcare and life sciences companies need to use it to solve historically intractable problems, not just streamline workflows. On The BioCentury Show, Owens breaks down how she evaluates founders, when Initiate chooses to fund versus co-found a company, and why she believes proprietary data now matters more than any proprietary model.Owens also discusses gaps in evidence generation for diagnostics, and closes with a look at MASH, arguing that better non-invasive fibrosis staging will become increasingly critical as more GLP-1 combination therapies reach patients.View full story: https://www.biocentury.com/article/660203#AI #VentureCapital #Diagnostics #HealthTech #DrugDevelopment00:00 - Introduction01:15 - Initiate Ventures' Thesis07:04 - What Makes Founders Fundable17:36 - Defining AI Native Healthcare23:20 - Diagnostics & Evidence Generation36:44 - Non-Invasive Fibrosis Testing